SIGNATURE ESTATE & INVESTMENT ADVISORS LLC

Position in LLY — ELI LILLY & Co

CIK 1079935 LOS ANGELES, CA

Position in LLY

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$69,037,996

+$16,375,646 QoQ

Shares Held

57,559

+0.5% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

3.72%

of 13F equity value

Holder Rank

#461

of 4,605 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

SIGNATURE ESTATE & INVESTMENT ADVISORS LLC holds $78,743,107 across 9 Drug Manufacturers - General names. LLY ranks #1 (87.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	57,559	$69,037,996
2	JNJ	Johnson & Johnson	8,972	$2,278,618
3	AMGN	Amgen Inc	6,232	$2,256,731
4	ABBV	AbbVie Inc.	5,312	$1,336,711
5	AZN	Astrazeneca PLC	6,802	$1,289,794
6	PFE	Pfizer Inc	38,803	$934,375
7	MRK	Merck & Co., Inc.	7,229	$928,926
8	NVO	Novo Nordisk A S	8,810	$422,350

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$69,037,996	57,559	+0.5%	Shares	Sole	2026-07-14
2026-03-31	$52,662,350	57,256	-21.1%	Shares	Sole	2026-04-15
2025-12-31	$77,999,206	72,579	-0.4%	Shares	Defined	2026-02-06
2025-09-30	$55,584,550	72,850	+31.4%	Shares	Sole	2025-11-05
2025-06-30	$43,211,685	55,433	+199.5%	Shares	Sole	2025-07-29
2025-03-31	$15,287,593	18,510	+1302.3%	Shares	Sole	2025-05-16
2024-12-31	$1,019,040	1,320	+3.3%	Shares	Sole	2025-02-11
2024-09-30	$1,132,230	1,278	+5.0%	Shares	Sole	2024-11-06
2024-06-30	$1,101,846	1,217	—	Shares	Sole	2024-07-26
No filing history on record for this holder in this stock.